Sector valuations Arcus Biosciences, Inc.
Equities
RCUS
US03969F1093
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.90 USD | +1.35% | +3.71% | -11.39% |
P/E ratio | Price to Book | PEG | EV / Sales | EV / EBITDA | EV / EBIT | Yield (Y) | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
-5.46x | 3.336 | 0.21x | 2.45x | -2.34x | -2.15x | -.--% | 1.53B | ||
47.72x | 4.097 | 1.64x | 6.34x | 22.29x | 34.27x | +0.84% | 46.68B | ||
30.53x | 6.128 | 5.37x | 3.53x | 14.68x | 17.35x | -.--% | 42.88B | ||
-105.75x | 123.19 | 3.39x | 14.2x | -242.98x | -178.64x | -.--% | 32.89B | ||
-8.63x | 2.899 | 0.34x | 7.26x | -6.84x | -6.06x | -.--% | 30.47B | ||
75.98x | 2.401 | -2.42x | 11.59x | 40.03x | 63.59x | +0.26% | 30.1B | ||
30.33x | 2.311 | 1.22x | 3x | 13.89x | 14.95x | -.--% | 23.23B | ||
13.84x | 2.049 | 0.55x | 4.56x | 8.89x | 9.19x | -.--% | 15.24B | ||
61.41x | 5.016 | 4.26x | 9.53x | 27.2x | 30.15x | +0.43% | 11.7B | ||
50.76x | 2.750 | -1.3x | 5.32x | 14.33x | 18.66x | -.--% | 10.2B | ||
28.29x | 10.65 | 0.93x | 4.4x | 21.13x | 22.71x | -.--% | 10.14B | ||
30.2x | 2.474 | -0.95x | 2.96x | 11.89x | 14.94x | -.--% | 9.81B | ||
-12x | 4.506 | 1.19x | 3482.26x | -8.82x | -8.7x | -.--% | 6.95B | ||
48.89x | 4.121 | 15.53x | 8.99x | 31.35x | 44.65x | +1.14% | 6.7B | ||
-11.52x | 9,590.50 | -0.26x | 8.99x | -11x | -10.47x | -.--% | 6.2B | ||
24.71x | 1.896 | -1.6x | 4.35x | 18.42x | 19.23x | +0.79% | 5.48B | ||
-69.02x | 73.50 | 0.81x | 9.42x | -20.59x | -20.55x | -.--% | 5.45B | ||
20.36x | 2.545 | 2.29x | 2.78x | 11.85x | 18.84x | +1.04% | 4.49B | ||
Average | 13.92x | 546.91 | 1.73x | 199.55x | -3.15x | 4.55x | +0.25% | 16.67B | |
Weighted average by Cap. | 16.10x | 216.23 | 1.82x | 87.58x | -13.17x | -0.49x | +0.23% |
- Stock Market
- Equities
- RCUS Stock
- Sector Arcus Biosciences, Inc.
- Sector valuations
MarketScreener is also available in this country: United States.
Switch edition